netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 6: Endocrine system - Full Section
Notes:

Endocrine-related Prescribing Guidance

Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter.

Endocrine-related Shared Care Agreements

Please see our Shared Care Agreements page for all shared care agreements (SCAs) relating to this chapter.

 

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
06.01 Drugs used in diabetes (0,0)
06.01.01 Insulins (0,0)
06.01.01.01 Short-acting insulins (8,9)
06.01.01.02 Intermediate- and long-acting insulins (9,5)
Biphasic insulins (4,3)
06.01.01.03 Hypodermic equipment (17,1)
06.01.02 Antidiabetic drugs (0,0)
06.01.02.01 Sulphonyureas (2,5)
06.01.02.02 Biguanides (2,0)
06.01.02.03 Other antidiabetic drugs (0,16)
Alpha glucosidase inhibitors (0,1)
DPP4 inhibitors (gliptins) (3,0)
GLP1 agonists (6,1)
Meglitinides (1,0)
SGL2 inhibitors (4,0)
Thiazolidinediones (1,0)
06.01.03 Diabetic ketoacidosis (0,0)
06.01.04 Treatment of hypoglycaemia (3,0)
Chronic hypoglycaemia (1,0)
06.01.05 Treatment of diabetic nephropathy and neuropathy (0,0)
06.01.06 Diagnostic and monitoring agents for diabetes mellitus (0,0)
Blood glucose monitoring (9,0)
Urinalysis (3,0)
Oral glucose tolerance test (1,1)
06.02 Thyroid and Antithyroid drugs (0,0)
06.02.01 Thyroid hormones (3,1)
06.02.02 Antithyroid drugs (3,1)
06.03 Corticosteroids (0,0)
06.03.01 Replacement therapy (1,0)
06.03.02 Glucocorticoid therapy (10,1)
Disadvantages of corticosteroids (0,0)
Use of corticosteroids (0,0)
Pregnancy and breastfeeding (0,0)
Administration (0,0)
Withdrawal of corticosteroids (0,0)
06.04 Sex hormones (0,0)
06.04.01 Female sex hormones and their modulators (1,0)
06.04.01.01 Oestrogens and HRT (17,1)
Ethinylestradiol (1,0)
Raloxifene (1,0)
Oestrogen only tablets (0,0)
06.04.01.02 Progestogens (5,1)
06.04.02 Male sex hormones and antagonists (2,0)
Anti-androgens (2,0)
06.04.03 Anabolic steroids (0,0)
06.05 Hypothalamic and pituitary hormones and anti-oestrogens (0,0)
06.05.01 Hypothalamic and anterior pituitary hormones and anti-oestrogens (0,0)
Anti-oestrogens (1,0)
Anterior pituitary hormones (7,1)
Hypothalmic hormones (2,0)
06.05.02 Posterior pituitary hormones and antagonists (0,0)
Posterior pituitary hormones (5,0)
Antidiuretic hormone antagonists (2,1)
06.06 Drugs affecting bone metabolism (0,0)
Osteoporosis (0,0)
06.06.01 Calcitonin and parathyroid hormone (1,1)
06.06.02 Bisphosphonates and other drugs affecting bone metabolism (0,0)
Bisphosphonates (8,0)
Denosumab (2,0)
Strontium renelate (1,0)
06.07 Other endocrine drugs (0,0)
06.07.01 Bromocriptine and other dopaminergic drugs (3,0)
06.07.02 Drugs affecting gonadotrophins (0,0)
Gonadorelin analogues (7,0)
Breast pain (mastalgia) (0,0)
06.07.03 Metyrapone (1,0)
06.07.04 Somatomedins (0,0)
netFormulary